Relation of obesity with some inflammatory cytokines in patients with COVID-19
DOI:
https://doi.org/10.15218/zjms.2025.019Keywords:
COVID-19, IL-2, IL-8, Exposed individuals, Vaccinated individuals, LymphocyteAbstract
Background and objective: Corona virus pandemic shifted research toward focusing on identifying individuals at risk of contracting the virus. New reports linked obesity with outcome of COVID19, cytokine storm been implicated in immunopathogenesis of COVID19. This study aimed to investigate the impact of bodyweight on the cytokine dysregulation in COVID-19 patients.
Methods: This study included 294 participants, classified into four groups: exposed, non-exposed, vaccinated and non-vaccinated, this classification made on the basis of viral exposure and vaccinations status. The participants further divided into obese and non-obese. The concentration levels of IL-2, IL-8 and lymphocyte measured for all the participants enrolled in this study.
Results: IL-2 concentration was moderately increased following vaccination in non-exposed and exposed individuals, the highest level (200 pg/ml) detected among COVID-19 exposed group. Similar changes were detected for IL-8 concentration following vaccination. The highest level of IL-8 (211.3 pg/ml) was among exposed-vaccinated group. In addition, vaccination induced lymphocyte counts in both control vaccinated and exposed vaccinated groups 31.4 cells/ml and 33.2 cells/ml respectively. Moreover, obese groups showed highest levels of both IL-2 and IL-8 concentrations in all study groups compared to non-obese ones, this finding was also applicable for the lymphocyte concentration levels but to lesser extent.
Conclusion: Obesity might increase the risk of developing a severe COVID-19 infection. Although there was upregulation in IL-2 and IL-8 among obese participants, but they were statistically non-significant. Vaccination could have a role in modulation of these cytokines.
Metrics
References
Lawal Y. Africa’s low COVID-19 mortality rate: A paradox? IJID. 2021; 102:118-22. doi: 10.1016/j.ijid.2020.10.038.
Jayawardena R, Jeyakumar DT, Francis TV, Misra A. Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries. Diabetes Metab Syndr. 2021; 15(3):757-64. doi: 10.1016/j.dsx 2021.03.006.
Nasr M-JC, Geerling E, Pinto AK. Impact of Obesity on Vaccination to SARS-CoV-2. Front. Endocrinol. 2022; 13. doi: 10.3389/fendo.2022.898810
Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications. 2021; 35(3):107817. doi: 10.1016/j.jdiacomp.2020.107817.
Watanabe M, Balena A, Tuccinardi D, Tozzi R, Risi R, Masi D, et al. Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab Res Rev. 2022; 38(1):e3465. doi: 10.1002/dmrr.3465.
Smith K, Smith M. Obesity Statistics. Primary Care: Clinics in Office Practice. Elsevier Health Science Philadelphia, PA, USA; 2016. doi: 10.1016/j.pop.2015.10.001.
Moriconi D, Masi S, Rebelos E, Virdis A, Manca ML, De Marco S, et al. Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding. Obes Res Clin Pract. 2020; 14(3):205-9. doi: 10.1016/j.orcp.2020.05.009
Yu T, Cai S, Zheng Z, Cai X, Liu Y, Yin S, et al. Association between clinical manifestations and prognosis in patients with COVID-19. Clin Ther. 2020; 42(6):964-72. doi: 10.1016/j.clinthera.2020.04.009.
Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2022; 22(1):1-12. doi: 10.1186/s12879-022-07418-y
Accorsi EK, Britton A, Fleming-Dutra KE, Smith ZR, Shang N, Derado G, et al. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants. JAMA. 2022; 327(7):639-51. doi: 10.1001/jama.2022.0470.
Tenforde MW, Patel MM, Gaglani M, Ginde AA, Douin DJ, Talbot HK, et al. Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults—United States, August–December 2021. MMWR Morb Mortal Wkly Rep. 2022; 71(4):118-24. doi: 10.15585/mmwr.mm7104a2.
Klein NP, Stockwell MS, Demarco M, Gaglani M, Kharbanda AB, Irving SA, et al. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19–associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5–17 Years—VISION Network, 10 States, April 2021–January 2022. MMWR Morb Mortal Wkly Rep. 2022; 71(9):352. doi: 10.15585/mmwr.mm7109e3.
McSharry D, Malhotra A. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity. J Clin Sleep Med. 2020; 16(9):1645-. doi: 10.5664/jcsm.8538.
Saleh RH, Mohammed HQ, Al-badri SAF. Comparative study of IL-2, IL-6 levels for recovered COVID-19 patients and vaccinated participants. Int J Health Sci. 2022; 6(s1). doi: 10.53730/ijhs.v6nS1.8319.
Zhang Y, Wang X, Li X, Xi D, Mao R, Wu X, et al. Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients. Cell Mol Immunol. 2020; 17(8):878-80. doi: 10.1038/s41423-020-0484-x
Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020; 26(10):1636-43. doi: 10.1038/s41591-020-1051-9.
Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunology letters. 2020; 225:31. doi: 10.1016%2Fj.imlet.2020.06.013
Obesity. Preventing and Managing the Global Epidemic. [Internet]. In: Technical Report Series No 894. 2000. https://apps.who.int/iris/handle/10665/42330.
Sunlong. Human Interleukin 2 (IL-2) ELISA Kit. In: SunLong Biotech Co. L, editor.
Sunglong. Human Interleukin 8 (IL-8) ELISA Ki. In: SunLong Biotech Co. L, editor.
de Oliveira Santos JG, Migueis DP, do Amaral JB, Bachi ALL, Boggi AC, Thamboo A, et al. Impact of SARS-CoV-2 on saliva: TNF-⍺, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM. J Oral Biosci. 2022; 64(1):108-13. doi: 10.1016/j.job.2022.01.007.
Kaiser R, Leunig A, Pekayvaz K, Popp O, Joppich M, Polewka V, et al. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. Jci Insight. 2021; 6(18). doi: 10.1172/jci.
Adnan Mezher M, Bahjat Alrifai S, Mahmood Raoof W. Analysis of Proinflammatory Cytokines in COVID-19 Patients in Baghdad, Iraq. Archives of Razi Institute. 2023; 78(1):305-13. doi: 10.22092/ARI.2022.359356.2411.
Ali AM, Tofiq AM, Rostam HM, Ali KM, Tawfeeq HM. Disease severity and efficacy of homologous vaccination among patients infected with SARS‐CoV‐2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers. J Med Virol. 2022; 94(12):5867-76. doi: 10.1002/jmv.28098.
Najim RH. Biochemical and hematological parameters as a predictor for COVID-19 infection in 65 patients diagnosed by real time? PCR in Kirkuk city. Sys Rev Pharm. 2020; 11(5):797-9. doi: 10.31838/srp.2020.5.117.
Kuperberg SJ, Navetta-Modrov B. The role of obesity in the immunopathogenesis of COVID-19 respiratory disease and critical illness. Am J Respir Cell Mol Biol. 2021; 65(1):13-21. doi: 10.1165/rcmb.2020-0236TR.
Maurya R, Sebastian P, Namdeo M, Devender M, Gertler A. COVID-19 severity in obesity: leptin and inflammatory cytokine interplay in the link between high morbidity and mortality. Front immunol. 2021:2349. doi: 10.3389/fimmu.2021.649359.
Bergantini L, d'Alessandro M, Cameli P, Otranto A, Luzzi S, Bianchi F, et al. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis. Cytokine. 2022; 151:155804. doi: 10.1016/j.cyto.2022.155804.
Bartuzi Z, Rosada T, Ukleja-Sokołowska N, Napiórkowska-Baran K, Lis K, Żbikowska-Gotz M, et al. Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in medical personnel. Postepy Dermatol Alergol. 2022; 39(5):913-22. DOI: doi: 10.5114/ada.2022.120884.
Korakas E, Ikonomidis I, Kousathana F, Balampanis K, Kountouri A, Raptis A, et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab. 2020; 319(1):E105-E9. doi: 10.1152/ajpendo.00198.2020.
Hassan RT, Mohammed SH. Impact of previous infection and body mass index on interferon-gamma and immunoglobulin G level generated against three types of vaccines available in Iraq. Biomed Biotechnol Res J. 2022; 6(4):576. doi: 10.4103/bbrj. bbrj_291_22.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Abdulla Kamil Abdulla, Ruqaya Muammed Gharib AL-Barzinji, Chato A. Taher (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
